Evidence map›Paper›PMID 41884533›Full record

ArticleFrontiers in cellular and infection microbiology2026

Molecular analysis of carbapenem-resistant

Jing Zhang, Dong Liu, Shan Li, Pengtao Wang, Wei Jia

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jing ZhangFirst Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, China.
Dong LiuContinuing Education College, Ningxia Medical University, Yinchuan, Ningxia, China.
Shan LiFirst Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, China.
Pengtao WangNingxia Key Laboratory of Clinical and Pathogenic Microbiology, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Wei JiaNingxia Key Laboratory of Clinical and Pathogenic Microbiology, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Infections caused by clinical carbapenem-resistant Methods: We collected clinical characteristic data of patients with isolated strains and conducted statistical analysis. Antibiotic susceptibility testing was conducted using the VITEK-2 compact system. Carbapenemase and virulence genes were examined through PCR and Sanger sequencing. Multilocus Sequence Typing (MLST) was performed according to the Oxford MLST scheme by comparing the obtained sequences with known allele sequences available on the MLST website (http://pubmlst.org/abaumannii/). The virulence of CRAB was assessed using the Results: The results indicated that all tested CRAB strains carried the Conclusion: The emergence of highly virulent multidrug-resistant CRAB strains in the Ningxia region has increased a clinical burden, highlighting the importance of clinical surveillance and diagnosis of these strains.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsBronchoalveolar Lavage FluidCarbapenemsAdultAgedAnimalsBacterial Proteinsbeta-LactamasesChinaFemaleGenotypeHumansMaleMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsVirulence Factorscarbapenem-resistant Acinetobacter baumanniimultilocus sequence typingresistanceST195virulence

Identifiers

PMID41884533
PMCPMC13008842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.